| COVID19F01 | COVID-19 vaccines Adverse events Response and Evaluation (CARE) Programme | 10000000 | 2020 | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F08 | The long term spill-over impact of COVID-19 on health and healthcare of patients with non-communicable diseases: an in-depth outcome and health economic evaluation | 9334600 | 2020 | Co-Investigator | | Ms Ng Carmen | Co-Investigator | | Dr Chao David Vai Kiong | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | Dr Ko Welchie | Co-Investigator | | Dr Lee Michael Shing Fung |
| Principal Investigator (PI) | | |
|
| COVID19F02 | To compare the reactogenicity and immunogenicity of the 3 recommended COVID-19 vaccines in young adolescents in Hong Kong | 10000000 | 2020 | Co-Investigator | | | Co-Investigator | | Dr Wong Wilfred Hing Sang | Co-Investigator | | | Co-Investigator | | Dr Cheong Kai Ning | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | Dr Cheong Kai Ning | Co-Investigator | | Mr Leung Daniel | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F04 | Psychobehavioural responses to COVID-19 and vaccine confidence in Hong Kong | 10000000 | 2020 | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F05 | Quantifying the impact of different public health and social measures on population mixing vis-à-vis contact matrices in Hong Kong | 9990378 | 2020 | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | Professor Jit Mark | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F09 | Randomized trial of COVID-19 booster vaccinations (Cobovax trial) | 7634012 | 2021 | Co-Investigator | | Dr Martin Sanchez Mario | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F10 | To compare the reactogenicity and immunogenicity of a third dose of the recommended COVID-19 vaccines in young adolescents in Hong Kong | 3910180 | 2021 | Co-Investigator | | Mr Leung Daniel | Co-Investigator | | Mr Wong Wilfred Hing Sang | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | Dr Cheong Kai Ning |
| Principal Investigator (PI) | | |
|
| COVID19F11 | Real-time psychobehavioural nowcasting from zero COVID-19 to sustainable endemicity in Hong Kong, 2022-2023 | 10000000 | 2021 | Co-Investigator | | Dr Ning Ke | Co-Investigator | | | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| COVID19F12 | To compare the reactogenicity and immunogenicity of the recommended COVID-19 vaccines via intradermal and intramuscular routes in children and adolescents in Hong Kong | 8758930 | 2021 | Co-Investigator | | Ms Cohen Carolyn Amanda | Co-Investigator | | | Co-Investigator | | Dr Mu Xiaofeng | Co-Investigator | | | Co-Investigator | | Mr Leung Daniel | Co-Investigator | | | Co-Investigator | | Dr Wong Wilfred Hing Sang |
| Principal Investigator (PI) | | |
|
